The increasing role of amphiregulin in non-small cell lung cancer

被引：14

作者：

Busser, B. ^{[1
,2
]}

Coll, J. -L. ^{[1
]}

Hurbin, A. ^{[1
]}

机构：

[1] Univ Grenoble 1, INSERM, U823, Inst Albert Bonniot, F-38042 Grenoble 9, France

[2] CHRU, Hop Michallon, UF Cancerol Biol & Biotherapie, F-38000 Grenoble, France

来源：

PATHOLOGIE BIOLOGIE | 2009年 / 57卷 / 7-8期

关键词：

Amphiregulin; Non-small cell lung cancer; Gefitinib; Growth factor; Apoptosis; Drug resistance; EGFR; Targeted therapy; Tyrosine kinase inhibitors; DEPENDENT PATHWAY; GROWTH; APOPTOSIS;

D O I：

10.1016/j.patbio.2008.10.002

中图分类号：

R36 [病理学];

学科分类号：

100103 [病原生物学];

摘要：

引用

页码：511 / 512

页数：2

共 5 条

[1]

Fontanini G, 1998, CLIN CANCER RES, V4, P241

[2]

Cooperation of amphiregulin and insulin-like growth factor-1 inhibits bax- and bad-mediated apoptosis via a protein kinase C-dependent pathway in non-small cell lung cancer cells [J].

Hurbin, A ;

Coll, JL ;

Dubrez-Daloz, L ;

Mari, B ;

Auberger, P ;

Brambilla, C ;

Favrot, MC .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (20) :19757-19767

[3]

Inhibition of apoptosis by amphiregulin via an insulin-like growth factor-1 receptor-dependent pathway in non-small cell lung cancer cell lines [J].

Hurbin, A ;

Dubrez, L ;

Coll, JL ;

Favrot, MC .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (51) :49127-49133

[4]

Increases of amphiregulin and transforming growth factor-α in serum as predictors of poor response to gefitinib among patients with advanced non-small cell lung cancers [J].

Ishikawa, N ;

Daigo, Y ;

Takano, A ;

Taniwaki, M ;

Kato, T ;

Hayama, S ;

Murakami, H ;

Takeshima, Y ;

Inai, K ;

Nishimura, H ;

Tsuchiya, E ;

Kohno, N ;

Nakamura, Y .

CANCER RESEARCH, 2005, 65 (20) :9176-9184

[5]

Epidermal growth factor receptor mutations in lung cancer [J].

Sharma, Sreenath V. ;

Bell, Daphne W. ;

Settleman, Jeffrey ;

Haber, Daniel A. .

NATURE REVIEWS CANCER, 2007, 7 (03) :169-181

← 1 →